2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide

SECTION 2: Hazards identification

Adverse Effects: Adverse effects may include numbness, burning, stinging or swelling of skin, drowsiness or excitement, nervousness, dizziness, blurred vision, tremors, convulsions, unconsciousness, and possible cardiac arrest. When taken orally, Lidocaine may cause nausea, vomiting, or abdominal discomfort. Possible allergic reaction to material if inhaled, ingested or in contact with skin. Overdose Effects: Symptoms of overdose include low blood pressure; blurred or double vision; nausea or vomiting; ringing in ears; tremors or twitching; difficult breathing; increased sweating; change in heart rate with possible cardiac arrest; pale skin; vision or hearing disturbances; feeling hot, cold, or numb; confusion; convulsions; dizziness; drowsiness; trembling; anxiety or nervousness; headache; weakness; coma; and death. Acute: Possible eye, skin, gastrointestinal and/or respiratory tract irritation. Chronic: Possible hypersensitization.

Medical Conditions Generally Aggravated by Exposure

Hypersensitivity to material, respiratory depression, existing cardiac conditions, and impaired liver orkidney function. Cross Sensitivity: Persons sensitive to other amide-type anesthetics, flecainide, or tocainide may be sensitive to this material also. Target Organs: Central nervous system and heart. For additional information on toxicity, see Section 11.